Viewing Study NCT07383818


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-29 @ 11:49 PM
Study NCT ID: NCT07383818
Status: RECRUITING
Last Update Posted: 2026-02-03
First Post: 2026-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module